Google Inc (NASDAQ GOOG) Stock News: Cost Per Click Rules Over Click-Through

Google Inc (NASDAQ GOOG)’s earnings results disappointed last week, or more specifically, one particular metric disappointed. Growth in paid clicks decelerated in the quarter, leaving investors with worries about Google’s near term growth. However, BGC analysts believe Wall Street is focusing on the wrong metric. They think growth in cost per click is more important than the deceleration in paid click growth. In a report … Continue reading Google Inc (NASDAQ GOOG) Stock News: Cost Per Click Rules Over Click-Through

Stock in News: DEA Extensively Uses Facebook Inc (NASDAQ FB) To Catch Drug Offenders

Facebook Inc (NASDAQ FB) is mad at the United States Drug Enforcement Administration for creating fake accounts to catch drug offenders. The social media giant sent a formal complaint to the DEA. Facebook recently sent a letter to the DEA asking them to stop impersonating users. The letter comes from Joe Sullivan (Facebook’s security chief officer) and it was addressed to DEA’s administrator Michele Leonhart. … Continue reading Stock in News: DEA Extensively Uses Facebook Inc (NASDAQ FB) To Catch Drug Offenders

Active Stock: Apple Inc (NASDAQ AAPL) And Nike Collaborating on New Wearables

Nike chief executive Mark Parker has hinted at a future collaboration with Apple on a new item of wearable technology, which will be more “stealth” than existing products. Since 2006 the two companies have partnered on wearable technology, with their first attempt marked by the Nike+ running which was released in 2006 and connected wirelessly to the iPod. News of the future collaboration follows on … Continue reading Active Stock: Apple Inc (NASDAQ AAPL) And Nike Collaborating on New Wearables

Biotech stock market news

Biotech Stocks Making Headlines: Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy

Pharmacyclics (PCYC) announced that it has teamed up with Roche (RHHBY) for evaluating the safety, tolerability and preliminary efficacy of its oncology treatment, Imbruvica, in combination with the latter’s Gazyva. The companies will assess the cocktail therapy in patients with non-hodgkin lymphoma (NHL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in multiple clinical trials. As per the deal, the combination will initially be evaluated in … Continue reading Biotech Stocks Making Headlines: Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy

Bitcoin News: Bitcoin Exchange Cryptsy Faces Lawsuit

A Florida law firm is pressing charges against digital currency exchange Cryptsy, accusing the company of fraudulent business practices and negligent security measures. In court documents filed in the 15th Judicial Court of Florida yesterday, Silver Law Firm stated that Cryptsy violated the state’s Deceptive and Unfair Trade Practices Act by failing to provide critical information regarding security risks and customer fund management protocols. Plaintiff … Continue reading Bitcoin News: Bitcoin Exchange Cryptsy Faces Lawsuit

Stock Update: Microsoft Corporation (NASDAQ MSFT) Pops Up Due To Earnings Beat

Shares of Microsoft Corporation climbed by as much as 3% in after-hours trading. Microsoft Corporation (NASDAQ MSFT) released the earnings results from its most recently completed quarter tonight after closing bell, posting non-GAAP earnings of 65 cents per share on $23.2 billion in revenue. Analysts had been expecting earnings of 49 cents per share on $22 billion in revenue. In the same quarter last year, … Continue reading Stock Update: Microsoft Corporation (NASDAQ MSFT) Pops Up Due To Earnings Beat